TJX Companies Inc (TJX) Stock Price Today
Aura AI Summary
Key Stats
- $166.78BMarket Cap
- -Volume
- Consumer CyclicalSector
- $168.4152W High
- $122.1752W Low
- -Typical Hold Time
- $175.38BEnterprise Value
- 1.27%Div Yield
- -Trading Activity
Track TJX Companies Inc (TJX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, TJX Companies Inc has traded between a low of $122.17 and a high of $168.41, highlighting its annual price range. Buy and sell TJX Companies Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About TJX Companies Inc
TJX is a leading off-price retailer of apparel, home fashions, and other merchandise. It sells a variety of branded goods, opportunistically buying inventory from a network of over 21,000 vendors worldwide. TJX targets undercutting conventional retailers' regular prices by 20%-60%, capitalizing on a flexible merchandising network, relatively low-frills stores, and a treasure-hunt shopping experience to drive margins and inventory turnover. TJX derived 79% of fiscal 2022 revenue from the United States, with 11% from Europe (mostly the United Kingdom and Germany), 9% from Canada, and the remainder from Australia. The company operated 4,689 stores at the end of fiscal 2022 under the T.J. Maxx, T.K. Maxx, Marshalls, HomeGoods, Winners, Homesense, Winners, and Sierra banners.
Most Recent News
Aduro and ECOCE complete Phase 1 of mapping flexible plastic waste in Mexico, starting HCT testing for circular recycling.
Aduro Clean Technologies and ECOCE have successfully completed Phase 1 of mapping flexible and multilayer plastic waste streams in Mexico, estimated at 1.5 million tons annually. The project now moves into testing these materials using Aduro's Hydroc...
Aduro and ECOCE advance to HCT testing for recycling Mexico's flexible plastic waste streams.
Aduro Clean Technologies and ECOCE have completed phase 1 of mapping flexible plastic waste streams in Mexico, estimated at 1.5 million tonnes annually. They are now moving selected post-consumer flexible packaging materials into Hydrochemolytic™ (HC...
FDA accepts resubmission of Camurus' CAM2029 NDA for acromegaly with decision due Dec 18, 2026
Camurus announced that the US FDA has accepted the resubmission of the New Drug Application (NDA) for CAM2029, an extended-release octreotide injection for treating acromegaly. The FDA set a Prescription Drug User Fee Act (PDUFA) target action date o...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.